Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).
$45.28-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+167.6%
The outlook
Sionna Therapeutics, Inc. currently reads as bullish based on buy — 1.5 avg of 10 analysts, above its 50- & 200-day averages, 82% of the way from its 52-week low to high, avg target +14% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.5 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range82% of the way from its 52-week low to high
Price targetAvg target +14% vs current price
Analyst price target
~12-month · 10 analysts$51.60average target+14.0% vs now
Now $45.28
Low $23.00High $63.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.04B
52-wk high
$51.57
52-wk low
$16.38
50-day avg
$41.47
200-day avg
$39.74
Trailing P/E
—